Bhargavi Kondragunta

Title: Bhargavi Kondragunta: Innovator in Recombinant AAV Production

Introduction

Bhargavi Kondragunta is a notable inventor based in Clarksburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the production of recombinant Adeno-Associated Virus (rAAV) particles. Her innovative methods have the potential to enhance the efficiency of viral vector production, which is crucial for gene therapy applications.

Latest Patents

Bhargavi holds 1 patent for her work titled "Scalable method for recombinant AAV production." This patent outlines improved methods for producing rAAV particles. The method involves culturing cells capable of producing rAAV particles in the presence of a histone deacetylase (HDAC) inhibitor. Additionally, it includes the use of an increased amount of a sodium salt to further enhance production efficiency.

Career Highlights

Bhargavi is currently associated with Regenxbio Inc., a company that focuses on gene therapy and the development of innovative treatments. Her work at Regenxbio has positioned her as a key player in advancing the field of gene therapy through her patented methods.

Collaborations

Throughout her career, Bhargavi has collaborated with talented professionals, including Matthieu Guibert and Miguel Valle. These collaborations have contributed to her success and the advancement of her research in the biotechnology sector.

Conclusion

Bhargavi Kondragunta's innovative approach to recombinant AAV production exemplifies her commitment to advancing gene therapy technologies. Her contributions are paving the way for more effective treatments in the field of medicine.